Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
9.76
-1.24 (-11.27%)
At close: Apr 28, 2026, 4:00 PM EDT
9.94
+0.18 (1.84%)
Pre-market: Apr 29, 2026, 7:50 AM EDT

Armata Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Net Income
-173.8-18.92-69.05-36.92-23.16
Upgrade
Depreciation & Amortization
1.531.330.970.891.17
Upgrade
Loss (Gain) From Sale of Assets
--0.08--
Upgrade
Asset Writedown & Restructuring Costs
5.41----
Upgrade
Stock-Based Compensation
2.612.890.943.112.88
Upgrade
Other Operating Activities
139.9-20.7529.28--1.25
Upgrade
Change in Accounts Payable
-0.33-3.760.043.670.18
Upgrade
Change in Other Net Operating Assets
-1.081.66-9.69-3.23-3.41
Upgrade
Operating Cash Flow
-25.76-37.55-47.42-32.48-23.58
Upgrade
Capital Expenditures
-0.54-1.88-8.14-2.21-1.3
Upgrade
Sale of Property, Plant & Equipment
--0.01--
Upgrade
Investing Cash Flow
-0.54-1.88-8.13-2.21-1.3
Upgrade
Long-Term Debt Issued
2534.8954.03--
Upgrade
Total Debt Issued
2534.8954.03--
Upgrade
Net Debt Issued (Repaid)
2534.8954.03--
Upgrade
Issuance of Common Stock
0.660.130.0144.5226.93
Upgrade
Repurchase of Common Stock
-0.05-0.06-0.04--
Upgrade
Other Financing Activities
----0.5-1.41
Upgrade
Financing Cash Flow
25.6134.9653.9944.0225.52
Upgrade
Net Cash Flow
-0.69-4.47-1.579.320.64
Upgrade
Free Cash Flow
-26.31-39.43-55.57-34.69-24.88
Upgrade
Free Cash Flow Margin
-536.40%-762.08%-1226.91%-629.85%-556.08%
Upgrade
Free Cash Flow Per Share
-0.73-0.67-1.54-1.01-1.03
Upgrade
Levered Free Cash Flow
-26.73-29.4-27.75-24.24-16.82
Upgrade
Unlevered Free Cash Flow
-16.36-22.69-26.11-24.24-16.78
Upgrade
Change in Working Capital
-1.41-2.1-9.650.44-3.22
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.